Preparation method for nucleic acid vaccine based on porcine circovirus
A technology for porcine circovirus and nucleic acid vaccines, applied in the field of preparation of porcine circovirus nucleic acid vaccines, can solve problems such as increased economic losses and reproductive barriers, and achieve the effects of reduced economic losses, good immune effects, and good safety
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment Construction
[0014] Embodiments of the present invention: based on the preparation method of porcine circovirus nucleic acid vaccine:
[0015] Eukaryotic expression plasmid pEGFP-C1-PCV2-ORF1, tryptone, yeast extract, sodium chloride, endotoxin-free plasmid extraction related reagents, etc.
[0016] Including the following steps:
[0017] First, the design and synthesis of primers
[0018] Primers were obtained from GeneBank (www.ncbi.nlm.nih.gov) to obtain SVP-321 strain (accession number: EU747085), Vos-2689006 strain (accession number: EU545551), P701-1 strain (accession number: FJ905468), PCV2 - HZ0201 strain (accession number: AY-188355) and PCV2herd D strain (accession number: EU136720) sequence, with Bioedit software comparison to select the conserved sequence after Primer Premier 5 software design porcine circovirus type Ⅱ ORF1 gene (with the sequence The nucleotide sequence shown in SEQ ID NO: 1 in the list) universal primer; the sequence of the upstream primer is Primer F 5'-CG...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com